| Bioactivity | Cyclo(RADfK) is a selective α(v)β(3) integrin ligand that has been extensively used for research, therapy, and diagnosis of neoangiogenesis. | ||||||
| Invitro | Cyclo(RADfK) is a negative control for the cyclo (-RGDfK-), the RGD peptide. RGD peptides are modulators of cell adhesion and are recognized by several members of the integrin family[1]. | ||||||
| Name | Cyclo(RADfK) | ||||||
| CAS | 756500-23-9 | ||||||
| Shortening | Cyclo(ADFKR) | ||||||
| Formula | C28H43N9O7 | ||||||
| Molar Mass | 617.70 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
Cyclo(RADfK)
CAS: 756500-23-9 F: C28H43N9O7 W: 617.70
Cyclo(RADfK) is a selective α(v)β(3) integrin ligand that has been extensively used for research, therapy, and diagnos
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.